Tezspire Speaker Series On Demand
VABYSMO: The First and Only Dual-Pathway-Inhibiting Therapy in DME and nAMD
Updates in the Diagnosis and Treatment Strategies for nr-axSpA
The Interconnected Cardio-Renal-Metabolic (CRM) Systems
Emily Strouphauer, BSA: Linking Pediatric Psoriasis to Anxiety, Depression
Raj Chovatiya, MD, PhD: Psoriasis Treatment Developments, FDA Approvals in 2022
Lawrence Eichenfield, MD: Phase 3 Trial Data on Ruxolitinib for Atopic Dermatitis
